German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma-Reference-Cited by-同舟云学术

German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma

Published:2002-01-31 Issue:2 Volume:51 Page:247-252
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Herrlinger Ulrich,Schabet Martin,Brugger Wolfram,Kortmann Rolf-Dieter,Küker Wilhelm,Deckert Martina,Engel Corinna,Schmeck-Lindenau Hans-Jürgen,Mergenthaler Hans-Günther,Krauseneck Peter,Benöhr Christian,Meisner Christoph,Wiestler Otmar D.,Dichgans Johannes,Kanz Lothar,Bamberg Michael,Weller Michael

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference19 articles.

1. Non-Hodgkin's lymphoma of the brain: can high-dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315;Nelson;Int J Radiat Oncol Biol Phys,1992

2. Combined modality therapy for primary CNS lymphoma;DeAngelis;J Clin Oncol,1992

3. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome;Glass;J Neurosurg,1994

4. Long-term survival in primary CNS lymphoma;Abrey;J Clin Oncol,1998

5. Treatment of primary CNS lymphoma: the next step;Abrey;J Clin Oncol,2000

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL);Neuro-Oncology;2022-08-12

3. Improvement of outcomes of an escalated high‐dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study;Cancer Management and Research;2021-08

4. Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX‐based regimens in clinical routine;European Journal of Haematology;2021-05-26

5. High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials;Scientific Reports;2021-01-22